221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1827576978089181184 |
---|---|
author | Katherine S Panageas Yanyun Li Margaret K Callahan James W Smithy Andrea P Moy Ronglai Shen Fiona Ehrich Colleen Maher Jasme Lee Xiyu Peng Nathaniel Aleynick Mingqiang Zhuang Travis Hollmann |
author_facet | Katherine S Panageas Yanyun Li Margaret K Callahan James W Smithy Andrea P Moy Ronglai Shen Fiona Ehrich Colleen Maher Jasme Lee Xiyu Peng Nathaniel Aleynick Mingqiang Zhuang Travis Hollmann |
author_sort | Katherine S Panageas |
collection | DOAJ |
first_indexed | 2024-03-08T21:20:13Z |
format | Article |
id | doaj.art-488d9b895cec4f1d8023e432e9de0675 |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-03-08T21:20:13Z |
publishDate | 2023-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-488d9b895cec4f1d8023e432e9de06752023-12-21T11:20:09ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0221221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanomaKatherine S Panageas0Yanyun Li1Margaret K Callahan2James W Smithy3Andrea P Moy4Ronglai Shen5Fiona Ehrich6Colleen Maher7Jasme Lee8Xiyu Peng9Nathaniel Aleynick10Mingqiang Zhuang11Travis Hollmann124Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USAMemorial Sloan-Kettering Cancer Center, New York, NY, USA |
spellingShingle | Katherine S Panageas Yanyun Li Margaret K Callahan James W Smithy Andrea P Moy Ronglai Shen Fiona Ehrich Colleen Maher Jasme Lee Xiyu Peng Nathaniel Aleynick Mingqiang Zhuang Travis Hollmann 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma Journal for ImmunoTherapy of Cancer |
title | 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma |
title_full | 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma |
title_fullStr | 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma |
title_full_unstemmed | 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma |
title_short | 221 Digital assessment of stromal B cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma |
title_sort | 221 digital assessment of stromal b cell aggregates as a biomarker of response to immune checkpoint inhibition in unresectable melanoma |
work_keys_str_mv | AT katherinespanageas 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT yanyunli 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT margaretkcallahan 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT jameswsmithy 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT andreapmoy 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT ronglaishen 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT fionaehrich 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT colleenmaher 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT jasmelee 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT xiyupeng 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT nathanielaleynick 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT mingqiangzhuang 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma AT travishollmann 221digitalassessmentofstromalbcellaggregatesasabiomarkerofresponsetoimmunecheckpointinhibitioninunresectablemelanoma |